Wang Ronghua 4
4 · Biostar Pharmaceuticals, Inc. · Filed Jun 14, 2011
Insider Transaction Report
Form 4
Wang Ronghua
DirectorChairman, CEO10% Owner
Transactions
- Purchase
Common Stock
2011-06-13$1.24/sh+22,050$27,298→ 9,103,723 total - Purchase
Common Stock
2011-06-10$1.21/sh+19,700$23,740→ 9,081,673 total
Footnotes (1)
- [F1]Purchase made pursuant to the stock repurchase plan of the Reporting Person as previously approved by the Board of Directors.